Skip to content
naulon
Not checkedNot checked for notices yet.

Ginsenoside Rb1 mitigates atherosclerosis in part through modulating FTO-mediated m6A RNA modification in NETs-induced endothelial activation

Zhenni Yang, Minqi Xiong, Minqi Xiong and 10 more

Frontiers in Pharmacology · 2025

doi:10.3389/fphar.2025.1631076 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

Background Ginsenoside Rb1 (Rb1) exerts pharmacological effects in attenuating the progression of atherosclerosis. However, whether the anti-atherosclerotic effects of Rb1 involve suppressing neutrophil extracellular traps (NETs)-induced endothelial activation and whether N 6 -methyadenosine (m 6 A) RNA modification is mechanistically implicated in this process remain unknown. Methods High fat diet (HFD)-fed Apoe −/− mice were subjected to histological, immunohistological and molecular biological analyses. Moreover, NETs-induced endothelial activation and m 6 A RNA methylation were assessed in human aortic endothelial cells (HAECs). Results Rb1 mitigated atherosclerotic lesions and endothelial activation in vivo . Rb1 diminished adhesion of neutrophils and monocytes to NETs-stimulated HAECs, offset NETs-upregulated endothelial expression of ICAM1 , VCAM1 , SELE and SELP , and counteracted NETs-induced endothelial barrier impairment in vitro . NETs exposure significantly decreased the level of m 6 A RNA methylation and increased the expression of demethylase fat mass and obesity-associated protein (FTO) in HAECs, whereas Rb1 treatment enhanced m 6 A RNA methylation and reduced FTO expression in the NETs-stimulated HAECs. Overexpression of FTO abrogated the protective effects of Rb1 against NETs-induced endothelial activation in HAECs. Furthermore, Fto overexpression in endothelial cells partially abolished Rb1-confered attenuation of atherosclerotic pathologies and the aortic expression of Vcam1 in HFD-fed Apoe −/− mice. Conclusion The work here demonstrates that Rb1 mitigates atherosclerosis in part by suppressing NETs-induced endothelial activation. Mechanistically, the pharmacological effects of Rb1 in attenuating NETs-induced endothelial activation are in part mediated by modulating FTO-mediated m 6 A RNA demethylation in endothelial cells.

Abstract licence: CC BY

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.